




Searching News Database: Servier
HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
HSMN NewsFeed - 29 Jan 2016
Viacoram(R) now approved in Canada as a new first line treatment in hypertension
Viacoram(R) now approved in Canada as a new first line treatment in hypertension
HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
HSMN NewsFeed - 16 Oct 2007
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
HSMN NewsFeed - 6 Jun 2007
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
HSMN NewsFeed - 17 May 2007
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
HSMN NewsFeed - 4 Oct 2006
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
HSMN NewsFeed - 17 Jul 2006
BioAlliance Pharma Strengthens International Capabilities in Key Legal, IP and Regulatory Departments
BioAlliance Pharma Strengthens International Capabilities in Key Legal, IP and Regulatory Departments
HSMN NewsFeed - 31 Jan 2006
Mark A. Varney, Ph.D. Named Chief Operating Officer and Chief Scientific Officer of Cortex Pharmaceuticals
Mark A. Varney, Ph.D. Named Chief Operating Officer and Chief Scientific Officer of Cortex Pharmaceuticals
Additional items found! 11

Members Archive contains
11 additional stories matching:
Servier
(Password required)
Servier
(Password required)